カテゴリ： MarketLine, パキスタン, 企業調査

Bank Alfalah Ltd：企業の戦略・SWOT・財務情報

◆英語タイトル：Bank Alfalah Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C11826
◆発行会社（調査会社）：MarketLine
◆発行日：2018年11月
◆ページ数：37
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：パキスタン
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Bank Alfalah Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Bank Alfalah Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Bank Alfalah Limited (Bank Alfalah) offers personal, business, and corporate banking solutions. Personal banking includes current, savings, and fixed deposits accounts, debit and credit cards, card acceptance solutions, auto, finance, and home loans, home remittance, and insurance. Business banking offers finance for fleet, business, merchant line, and agri loans. Corporate banking contains transaction banking cash management, trade finance, capital market operations, financing solutions, treasury solutions, and financial institutions. It offers products and services through a network of branch offices, ATMs, and online platforms to individual and commercial clients in Pakistan, Bangladesh, Afghanistan, and Bahrain. Bank Alfalah is headquartered in Karachi, Pakistan.

Scope

- Detailed information on Bank Alfalah Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Bank Alfalah Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Bank Alfalah Ltd including a breakdown and examination of key business segments
- Intelligence on Bank Alfalah Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Bank Alfalah Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Bank Alfalah Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Bank Alfalah Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Bank Alfalah Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Bank Alfalah Ltd: Company Overview 9
Bank Alfalah Ltd: Overview and Key Facts 9
Bank Alfalah Ltd: Overview 9
Bank Alfalah Ltd: Key Facts 9
Bank Alfalah Ltd: Key Employees 11
Bank Alfalah Ltd: Key Employee Biographies 13
Bank Alfalah Ltd: Major Products and Services 14
Bank Alfalah Ltd: Company History 16
Bank Alfalah Ltd: Management Statement 18
Bank Alfalah Ltd: Locations and Subsidiaries 20
Bank Alfalah Ltd: Key Competitors 22
Bank Alfalah Ltd: Company Analysis 23
Bank Alfalah Ltd: Business Description 23
Bank Alfalah Ltd: SWOT Analysis 25
Bank Alfalah Ltd: SWOT Overview 25
Bank Alfalah Ltd: Strengths 25
Bank Alfalah Ltd: Weaknesses 26
Bank Alfalah Ltd: Opportunities 26
Bank Alfalah Ltd: Threats 26
Bank Alfalah Ltd: Corporate Financial Deals Activity 28
Bank Alfalah Ltd: Financial Deals Overview 28
Bank Alfalah Ltd: Top Deals 2014 – 2018YTD* 29
Bank Alfalah Ltd: Divestments 30
Bank Alfalah Ltd: Private Equity and Ownership 31
Bank Alfalah Ltd: Recent Developments 32
Bank Alfalah Ltd: News and Events Summary 32
Bank Alfalah Ltd: Business Expansion 32
Bank Alfalah Ltd: Corporate Governance 33
Bank Alfalah Ltd: Regulatory and Legal Events 33
Bank Alfalah Ltd: Strategy and Operations 33
Appendix 35
Contact Us 35
Methodology 35
About MarketLine 36

List of Tables
Table 1: Bank Alfalah Ltd: Key Facts
Table 2: Bank Alfalah Ltd: Key Employees
Table 3: Bank Alfalah Ltd: Company History
Table 4: Bank Alfalah Ltd: Locations and Subsidiaries
Table 5: Bank Alfalah Ltd: Key Competitors
Table 6: Bank Alfalah Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Bank Alfalah Ltd: Top Deals 2014 - 2018YTD*
Table 8: Bank Alfalah Ltd: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 9: Bank Alfalah Ltd: Divestments by Geography (2014 - YTD*2018)
Table 10: Bank Alfalah Ltd: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 11: Bank Alfalah Ltd: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 12: Bank Alfalah Ltd: News and Events Summary
Table 13: Bank Alfalah Ltd: Business Expansion
Table 14: Bank Alfalah Ltd: Corporate Governance
Table 15: Bank Alfalah Ltd: Regulatory and Legal Events
Table 16: Bank Alfalah Ltd: Strategy and Operations

List of Figures
Figure 1: Bank Alfalah Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Bank Alfalah Ltd: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 3: Bank Alfalah Ltd: Divestments by Geography (2014 - YTD*2018)
Figure 4: Bank Alfalah Ltd: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 5: Bank Alfalah Ltd: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Bank Alfalah Ltd：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Metropolitan Bank & Trust Company (MBT)：企業の財務・戦略的SWOT分析
    Metropolitan Bank & Trust Company (MBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Faron Pharmaceuticals Oy (FARN)：企業の財務・戦略的SWOT分析
    Summary Faron Pharmaceuticals Oy (Faron) is a clinical stage biopharmaceutical company that develops treatments for unmet medical needs. The company is developing pipeline products with a focus on vascular damage, acute organ traumas and cancer immunotherapy. It offers Clevegen, a humanized Clever-1 …
  • ICA Gruppen AB：企業の戦略・SWOT・財務情報
    ICA Gruppen AB - Strategy, SWOT and Corporate Finance Report Summary ICA Gruppen AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Perilya Limited：企業の戦略・SWOT・財務情報
    Perilya Limited - Strategy, SWOT and Corporate Finance Report Summary Perilya Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Natera Inc (NTRA)：企業の財務・戦略的SWOT分析
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …
  • Centers for Disease Control and Prevention-医療機器分野：企業M&A・提携分析
    Summary Centers for Disease Control and Prevention (CDC), a subsidiary of US Department of Health and Human Services is a public health institute that offers health, safety and security threat management solutions. The institute provides health information to fight diseases and support communities f …
  • Clinical Trial Consultants AB：製薬・医療：M&Aディール及び事業提携情報
    Summary Clinical Trial Consultants AB (CTC AB) is a contract research organization that conducts hospital-based early phase clinical trials. The organization offers services which include pharmacovigilance, human PET imaging studies, medical and scientific advisory, quality assurance and outsourcing …
  • Grande Asset Hotels And Property Pcl：企業の戦略・SWOT・財務分析
    Grande Asset Hotels And Property Pcl - Strategy, SWOT and Corporate Finance Report Summary Grande Asset Hotels And Property Pcl - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Apetit Oyj：戦略・SWOT・企業財務分析
    Apetit Oyj - Strategy, SWOT and Corporate Finance Report Summary Apetit Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Deutsche Telekom AG (DTE)：企業の財務・戦略的SWOT分析
    Deutsche Telekom AG (DTE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Ramsay Health Care Limited：企業の戦略・SWOT・財務情報
    Ramsay Health Care Limited - Strategy, SWOT and Corporate Finance Report Summary Ramsay Health Care Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Agappe Diagnostics Ltd：医療機器：M&Aディール及び事業提携情報
    Summary Agappe Diagnostics Ltd (Agappe) is an in vitro diagnostic company that manufactures clinical chemistry and immuno turbidimetry products. The company’s products categories include biochemistry, immunochemistry, serology, coagulation, hematology, system reagents, controls and calibrators; poin …
  • Brenntag AG：企業のM&A・事業提携・投資動向
    Brenntag AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Brenntag AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Emzor Pharmaceutical Industries Ltd：企業の戦略的SWOT分析
    Emzor Pharmaceutical Industries Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • The Procter & Gamble Co：企業のM&A・事業提携・投資動向
    The Procter & Gamble Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Procter & Gamble Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Intrexon Corp (XON)-医療機器分野：企業M&A・提携分析
    Summary Intrexon Corp (Intrexon), formerly Genomatix Corp is a provider of therapeutic solutions. The company operates through its divisions such as human therapeutics, protein production, industrial products, agricultural biotech, and animal sciences. Its human therapeutics division develops therap …
  • Vapotherm Inc：医療機器：M&Aディール及び事業提携情報
    Summary Vapotherm Inc (Vapotherm) is a medical device company that develops and manufactures advanced non-invasive respiratory care devices. The company offers products such as Precision Flow products and accessories, medical-grade vapor, disposable patient circuit, nitric oxide disposable patient c …
  • Valence Health-製薬・医療分野：企業M&A・提携分析
    Summary Valence Health is a healthcare company that provides healthcare services. The company offers solutions such as consulting, vision platform, quality measurement, cost and utilization, data collection, contract administration, managed services, and actuarial services. It provides health care s …
  • NuVascular Technologies Inc：企業の製品パイプライン分析2018
    Summary NuVascular Technologies Inc (NuVascular Technologies) is a developer of medical devices for the treatment of patients suffering from end-stage renal diseases. The company offers hemodialysis access grafts, arteriovenous suture, central venous catheter cuffs, drug-eluting vessel wrap, drug-el …
  • Tata Chemicals Ltd (TATACHEM)：企業の財務・戦略的SWOT分析
    Summary Tata Chemicals Ltd (TCL) is a chemical company engaged in offering industry, living, and farm essential chemicals. The company's products include dals, consumer salt, water purifier, soda ash, spices, sodium bicarbonate, allied chemicals, industrial salt, customized fertilizers, cement, fert …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆